- Home
- BMRN vs AYI Comparison
BMRN vs AYI Comparison
Compare BMRN & AYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | AYI |
|---|---|---|
| Founded | 1996 | 2001 |
| Country | United States | United States |
| Employees | 3221 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Products |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 10.2B |
| IPO Year | 1999 | 2001 |
Fundamental Metrics
Financial Performance| Metric | BMRN | AYI |
|---|---|---|
| Price | $55.48 | $284.55 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 6 |
| Target Price | $88.22 | ★ $369.17 |
| AVG Volume (30 Days) | ★ 1.7M | 436.9K |
| Earning Date | 04-30-2026 | 04-02-2026 |
| Dividend Yield | N/A | ★ 0.28% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.80 | ★ 6.91 |
| Revenue | $1,313,646,000.00 | ★ $3,461,000,000.00 |
| Revenue This Year | $15.02 | $9.72 |
| Revenue Next Year | $12.23 | $5.37 |
| P/E Ratio | ★ $30.52 | $41.04 |
| Revenue Growth | ★ 17.62 | 4.05 |
| 52 Week Low | $50.76 | $225.71 |
| 52 Week High | $66.28 | $380.17 |
Technical Indicators
Market Signals| Indicator | BMRN | AYI |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 53.39 |
| Support Level | $51.77 | $282.78 |
| Resistance Level | $56.21 | $290.35 |
| Average True Range (ATR) | 1.36 | 8.73 |
| MACD | 0.08 | 2.44 |
| Stochastic Oscillator | 41.16 | 81.20 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About AYI Acuity Brands Inc.
Acuity is a leading industrial technology company that offers lighting, lighting controls, and intelligent building solutions. It designs, manufactures, and brings to market products and services relating to these and other offerings. Acuity has two reportable segments: Acuity Brands Lighting and Acuity Intelligent Spaces. ABL sells commercial, architectural, and specialty lighting, including components and control systems. AIS offers building management and audio/visual solutions to help make buildings intelligent.